Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

In a major positive step for global respiratory health, Member States at the 78th World Health Assembly (WHA), held May 19–27 ...

The ACG has published new health maintenance recommendations for patients with IBD, which include appropriate vaccinations, ...

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...

Increasing environmental events driven by climate change and human activity exacerbate allergy and asthma conditions, further compounded by exposure to persistent pollutants like per-and ...

Medical experts are dismayed over a federal report's claim that kids are overprescribed asthma medications, saying it ...

A bill passed by New York lawmakers on June 12 would eliminate out-of-pocket costs for asthma inhalers if signed by Governor Kathy Hochul.

The CDC currently lists the price for a Pfizer or Moderna COVID-19 vaccine at about $150. However, Ruiz said the cost could rise to somewhere between $500 and $1,000.